RNU7-35P: A Promising Drug Target / Biomarker (G100147822)

Target Name: RNU7-35P

NCBI ID: G100147822

RNU7-35P

Other Name(s): U7.35 | RNA, U7 small nuclear 35 pseudogene

RNU7-35P: A Promising Drug Target / Biomarker

The identifier RNAU7-35P is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. RNAU7-35P is a small non-coding RNA molecule that is found in various tissues and cells in the human body. It is characterized by its unique structure, which consists of a single exon that is usually expressed at low levels.

The discovery of RNAU7-35P

RNAU7-35P was first identified using RNA sequencing techniques. Researchers found that RNAU7-35P is a single-exon RNA molecule that is expressed in various tissues and cells in the human body. The molecule is characterized by its unique structure, which consists of a single exon that is usually expressed at low levels.

The potential drug target or biomarker properties of RNAU7-35P

RNAU7-35P has been shown to have various potential drug target or biomarker properties. One of the most promising potential drug targets for RNAU7-35P is its role in cancer. Studies have shown that high levels of RNAU7-35P are associated with poor prognosis in various types of cancer, including breast, ovarian, and colorectal cancers.

RNAU7-35P has also been shown to play a role in inflammation. Studies have shown that RNAU7-35P is involved in the regulation of inflammation-related genes, including those that are involved in the production of pro-inflammatory cytokines. This suggests that RNAU7-35P may be a potential therapeutic target for treating inflammatory diseases.

The potential utility of RNAU7-35P as a drug target or biomarker

The potential utility of RNAU7-35P as a drug target or biomarker is due to its unique structure and various biochemical properties. The single-exon structure of RNAU7-35P allows it to have unique interactions with other molecules, which may be involved in its function. Additionally, RNAU7-35P has been shown to have various functions in various cellular processes, including cell growth, apoptosis, and inflammation.

RNAU7-35P may also be a potential biomarker for various diseases, including cancer and inflammatory diseases. Studies have shown that high levels of RNAU7-35P are associated with poor prognosis in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, RNAU7-35P has been shown to be involved in the regulation of inflammation-related genes, which suggests that it may be a potential therapeutic target for treating inflammatory diseases.

Conclusion

RNAU7-35P is a small non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and various biochemical properties make it a promising candidate for further study. Further research is needed to determine the full potential of RNAU7-35P as a drug target or biomarker.

Protein Name: RNA, U7 Small Nuclear 35 Pseudogene

The "RNU7-35P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU7-35P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets